AAID Whitened Paper Treating the Dental care Implant Individual Throughout the COVID19 Pandemic and also Beyond: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 December 2023

  • curprev 13:2413:24, 29 December 2023‎ 170.83.176.253 talk‎ 3,544 bytes +3,544‎ Created page with "v.; BU2) or older (A dozen.7 mg/kg we./.; BU4) amounts in a fludarabine/i.versus. busulfan (FLU/BU) strategy. Among 475 sufferers who have their particular initial CBT pursuing FLU/BU health and fitness involving 3 years ago and 2018, 162 acquired BU2 as well as 313 acquired BU4. Multivariate evaluation recognized BU4 as being a significant factor for extended disease-free success (danger percentage [HR], .80; 95% self-assurance period of time [CI], .75 for you to .Ninet..."
Retrieved from "https://news.npo.digital/index.php?title=AAID_Whitened_Paper_Treating_the_Dental_care_Implant_Individual_Throughout_the_COVID19_Pandemic_and_also_Beyond"